Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

UPS and Labor Union Still Haven't Reached Agreement

Contract negotiations between UPS and the union representing 340,000 of the company's workers broke down early Wednesday with each side blaming the other for walking away from talks.

Jenny Craig to Become E-Commerce Business

Jenny Craig to Become E-Commerce Business

Be Well: Assessing the State of the Housing Market With Marty Cantor

Be Well: Assessing the State of the Housing Market

Meta Looks to Target Twitter With a Rival App Called Threads

Meta is poised to launch a new app that appears to mimic Twitter, marking a direct challenge to the social media platform owned by billionaire Elon Musk.

Retailers, Beware: Resumption of Student Loan Payments Could Lead Some Buyers to Pull Back

The average borrower will have about $305 less to spend as payments begin for the first time since March 2020, according to a Deutsche Bank estimate.

United Airlines Gives 30,000 Frequent Flyer Miles Away

United Airlines Gives 30,000 Frequent Flyer Miles Away

Tesla Surprises Analysts, Breaks Delivery Record

Tesla Surprises Analysts, Breaks Delivery Record

What Hotels Don't Tell You About Hidden Fees

What Hotels Don't Tell You About Hidden Fees

Sriracha Shortage Leads to Soaring Prices

Sriracha Shortage Leads to Soaring Prices

Taylor Swift's 'Eras Tour' On Pace to Cross Billion Dollar Mark

Taylor Swift's 'Eras Tour' On Pace to Cross Billion Dollar Mark

Load More